[1]
Biering-Soerensen, B. et al. 2022. European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A. Journal of Rehabilitation Medicine. 54, (Jan. 2022), jrm00241. DOI:https://doi.org/10.2340/16501977-2877.